Jonathan D. Cooper, PhD, a professor of pediatrics, of genetics and of neurology at the Washington University School of Medicine in St. Louis, received two grants totaling $2.55 million over five years from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH).
Cooper will study enzyme replacement therapy as a possible treatment for CLN1, a rare genetic disease that is fatal in children. The grant is in collaboration with the University of Edinburgh in Scotland.
